| Q28591022 | Absence of direct cyclic nucleotide modulation of mEAG1 and hERG1 channels revealed with fluorescence and electrophysiological methods |
| Q34186476 | Alternative Splicing and Polyadenylation Contribute to the Generation of hERG1 C-terminal Isoforms |
| Q39630130 | Anti-proliferative effect of Kv1.3 blockers in A549 human lung adenocarcinoma in vitro and in vivo |
| Q36230637 | Arsenic trioxide induces the apoptosis of human breast cancer MCF-7 cells through activation of caspase-3 and inhibition of HERG channels |
| Q38907773 | Blockage of potassium channel inhibits proliferation of glioma cells via increasing reactive oxygen species |
| Q61813958 | Cancer-Associated Intermediate Conductance Ca-Activated K⁺ Channel K3.1 |
| Q39434223 | Constitutive expression of a Mg2+-inhibited K+ current and a TRPM7-like current in human erythroleukemia cells |
| Q39426349 | Curcumin blocks Kv11.1 (erg) potassium current and slows proliferation in the infant acute monocytic leukemia cell line THP-1. |
| Q39693128 | Cysteine 723 in the C-linker segment confers oxidative inhibition of hERG1 potassium channels. |
| Q48130718 | Developmentally regulated expression of the mouse homologues of the potassium channel encoding genes m-erg1, m-erg2 and m-erg3. |
| Q42660203 | Differential expression of hERG1A and hERG1B genes in pediatric acute lymphoblastic leukemia identifies different prognostic subgroups. |
| Q21245576 | Eag and HERG potassium channels as novel therapeutic targets in cancer |
| Q43263512 | Effect of Gambogic acid on the regulation of hERG channel in K562 cells in vitro |
| Q40341709 | Effects of TRH on heteromeric rat erg1a/1b K+ channels are dominated by the rerg1b subunit |
| Q35857269 | Effects of Tannic Acid, Green Tea and Red Wine on hERG Channels Expressed in HEK293 Cells |
| Q46054857 | Ether-à-go-go-related gene K+ channels contribute to threshold excitability of mouse auditory brainstem neurons |
| Q53539252 | Expression and functional role of HERG1, K+ channels in leukemic cells and leukemic stem cells. |
| Q84920028 | Expression and immunolocalization of ERG1 potassium channels in the rat kidney |
| Q40293400 | Expression of potassium channel isoforms mRNA in normal human adrenals and aldosterone-secreting adenomas |
| Q48799646 | Expression pattern of the ether-a-go-go-related (ERG) family proteins in the adult mouse central nervous system: evidence for coassembly of different subunits. |
| Q45958846 | Functional expression of ERG1 potassium channels in rat alveolar macrophages. |
| Q42642223 | Genomic structure, transcriptional control, and tissue distribution of HERG1 and KCNQ1 genes |
| Q39991467 | HERG K+ channel expression in CD34+/CD38-/CD123(high) cells and primary leukemia cells and analysis of its regulation in leukemia cells |
| Q33915930 | HERG1 channelopathies |
| Q40086589 | HERG1 currents in native K562 leukemic cells |
| Q51768648 | HERG1 potassium channel expression in potentially malignant disorders of the oral mucosa and prognostic relevance in oral squamous cell carcinoma. |
| Q36501076 | HERG1A potassium channel is the predominant isoform in head and neck squamous cell carcinomas: evidence for regulation by epigenetic mechanisms |
| Q40440867 | Human ether-a-go-go-related gene 1 channels are physically linked to beta1 integrins and modulate adhesion-dependent signaling |
| Q39403710 | Human ether-a-go-go-related gene K+ channels regulate shedding of leukemia cell-derived microvesicles |
| Q64095235 | Hypoxia induced hERG trafficking defect linked to cell cycle arrest in SH-SY5Y cells |
| Q39971749 | Identification of a posttranslational mechanism for the regulation of hERG1 K+ channel expression and hERG1 current density in tumor cells |
| Q54334505 | Imatinib has the potential to exert its antileukemia effects by down-regulating hERG1 K+ channels in chronic myelogenous leukemia. |
| Q53122379 | Increased expression of HERG K+ channels contributes to myelodysplastic syndrome progression and displays correlation with prognosis stratification. |
| Q39444757 | Inhibition of HERG1 K+ channel protein expression decreases cell proliferation of human small cell lung cancer cells |
| Q42625345 | Inhibition of human ether-a-go-go-related gene potassium channels by alpha 1-adrenoceptor antagonists prazosin, doxazosin, and terazosin |
| Q37856596 | Ion channels and transporters in cancer. 1. Ion channels and cell proliferation in cancer |
| Q34372638 | Isoform-specific dominant-negative effects associated with hERG1 G628S mutation in long QT syndrome |
| Q41849048 | K(+) channels and cell cycle progression in tumor cells |
| Q37855925 | K(+) channels as therapeutic targets in oncology. |
| Q38938416 | Large-scale mutational analysis of Kv11.1 reveals molecular insights into type 2 long QT syndrome |
| Q34024653 | Long-term channel block is required to inhibit cellular transformation by human ether-à-go-go-related gene (hERG1) potassium channels. |
| Q27728045 | Molecular Insights into the Mechanism of Calmodulin Inhibition of the EAG1 Potassium Channel |
| Q37783442 | New Insights into the Regulation of Ion Channels by Integrins |
| Q38974256 | New Trends in Cancer Therapy: Targeting Ion Channels and Transporters |
| Q27015660 | Novel roles for hERG K(+) channels in cell proliferation and apoptosis |
| Q40169058 | Overexpression HERG K(+) channel gene mediates cell-growth signals on activation of oncoproteins SP1 and NF-kappaB and inactivation of tumor suppressor Nkx3.1. |
| Q98386206 | Pathological role of ion channels and transporters in the development and progression of triple-negative breast cancer |
| Q42061814 | Placing ion channels into a signaling network of T cells: from maturing thymocytes to healthy T lymphocytes or leukemic T lymphoblasts. |
| Q52062790 | Postnatal development of E-4031-sensitive potassium current in rat carotid chemoreceptor cells. |
| Q36973723 | Potassium channel activation inhibits proliferation of breast cancer cells by activating a senescence program |
| Q36511047 | Potassium channels as tumour markers |
| Q38184978 | Potassium channels in cell cycle and cell proliferation. |
| Q35753771 | Probing the outer mouth structure of the HERG channel with peptide toxin footprinting and molecular modeling. |
| Q53391411 | Prognostic significance of hERG1 expression in gastric cancer. |
| Q39783110 | Regulation of HERG (KCNH2) potassium channel surface expression by diacylglycerol |
| Q37767379 | Role of ERG1 isoforms in modulation of ERG1 channel trafficking and function |
| Q54365048 | Role of hERG1 K(+) channels in leukemia cells as a positive regulator in SDF-1a-induced proliferation. |
| Q36345940 | Role of voltage-gated potassium channels in cancer. |
| Q35719297 | Roles of K+ channels in regulating tumour cell proliferation and apoptosis |
| Q34279096 | SK3-1C, a dominant-negative suppressor of SKCa and IKCa channels |
| Q39545346 | Sec62 protein level is crucial for the ER stress tolerance of prostate cancer |
| Q37535568 | Serum starvation-induced voltage-gated potassium channel Kv7.5 expression and its regulation by Sp1 in canine osteosarcoma cells |
| Q35176400 | Stimulation of hERG1 channel activity promotes a calcium-dependent degradation of cyclin E2, but not cyclin E1, in breast cancer cells |
| Q33937726 | Targeting potassium channels in cancer |
| Q35767632 | The 2P-domain K+ channels: role in apoptosis and tumorigenesis |
| Q58109074 | The Interaction between the Drosophila EAG Potassium Channel and the Protein Kinase CaMKII Involves an Extensive Interface at the Active Site of the Kinase |
| Q38243381 | The enigmatic cytoplasmic regions of KCNH channels |
| Q36734932 | The hERG potassium channel as a therapeutic target |
| Q24324091 | The regulation of the cardiac potassium channel (HERG) by caveolin-1 |
| Q27497208 | The role of Eag and HERG channels in cell proliferation and apoptotic cell death in SK-OV-3 ovarian cancer cell line |
| Q38171243 | The roles of K(+) channels in cancer |
| Q24294672 | Voltage-gated potassium channel EAG2 controls mitotic entry and tumor growth in medulloblastoma via regulating cell volume dynamics |
| Q37464784 | Voltage-gated potassium channels as therapeutic targets |
| Q36901507 | ZC88, a novel 4-amino piperidine analog, inhibits the growth of neuroblastoma cells through blocking hERG potassium channel |
| Q94544689 | hERG K+ Channels Promote Survival of Irradiated Leukemia Cells |
| Q43487048 | hERG K+ channel-associated cardiac effects of the antidepressant drug desipramine |
| Q27008078 | hERG channel function: beyond long QT |
| Q35081094 | hERG potassium channel blockage by scorpion toxin BmKKx2 enhances erythroid differentiation of human leukemia cells K562 |
| Q26784422 | hERG1 Potassium Channels: Novel Biomarkers in Human Solid Cancers |
| Q39495923 | hERG1 behaves as biomarker of progression to adenocarcinoma in Barrett's esophagus and can be exploited for a novel endoscopic surveillance |
| Q36615364 | hERG1 channels are overexpressed in glioblastoma multiforme and modulate VEGF secretion in glioblastoma cell lines |
| Q38959783 | hERG1 potassium channel in cancer cells: a tool to reprogram immortality |
| Q47581050 | hERG1a and hERG1b potassium channel subunits directly interact and preferentially form heteromeric channels. |
| Q51680757 | hLH/hCG-receptor expression correlates with in vitro invasiveness in human primary endometrial cancer. |
| Q54191017 | herg1b expression as a potential specific marker in pediatric acute myeloid leukemia patients with HERG 897K/K genotype. |